Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
Mathematical Modeling: Problem Solving01:29

Mathematical Modeling: Problem Solving

Mathematical modeling transforms real-world scenarios into mathematical expressions, allowing for structured problem-solving and analysis. This process involves defining the situation, assigning variables to measurable quantities, selecting an appropriate model, and solving the resulting equation. Such models are invaluable in finance, providing precise methods to evaluate investments, loans, and repayment structures.A widely used example is the calculation of fixed monthly payments on a loan,...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lessons Learned from the Feasibility Phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial Program.

American heart journal·2026
Same author

Population Prevalence of Valvular Heart Disease in the United States: The PREVUE-VALVE Study.

Journal of the American College of Cardiology·2026
Same author

Systematic estimates of global causes of neonatal and under 5 mortality in 2000-24: secondary data analysis using bayesian multinomial logistic regression.

BMJ (Clinical research ed.)·2026
Same author

Estimates of global causes of death for children and adolescents aged 5-19 in 2000-24: secondary data analysis using bayesian multinomial logistic regression.

BMJ (Clinical research ed.)·2026
Same author

Alcohol availability around schools and adolescent consumption: A case study in Madrid, Spain.

Health & place·2026
Same author

Invasive vs Conservative Strategy for Frail Older Patients With Myocardial Infarction: A Secondary Analysis of the SENIOR-RITA Randomized Clinical Trial.

JAMA network open·2026

Related Experiment Video

Updated: May 20, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

The science of risk models.

David Prieto-Merino1, Stuart J Pocock

  • 1Department of Medical Statistics, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.

European Journal of Preventive Cardiology
|July 18, 2012
PubMed
Summary
This summary is machine-generated.

Developing accurate cardiovascular risk scores is crucial for guiding patient therapy. Continuous updates are needed to incorporate new data, treatments, and risk factors for better disease prediction.

Related Experiment Videos

Last Updated: May 20, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

  • Cardiology
  • Biostatistics
  • Epidemiology

Background:

  • Cardiovascular risk assessment guides patient management and therapy.
  • Existing risk scores require updates to reflect evolving treatments, lifestyles, and emerging risk factors.
  • Enhanced risk algorithms are needed for targeted risk measurement across diverse patient subpopulations.

Purpose of the Study:

  • To outline the essential components and considerations for developing and refining cardiovascular risk models.
  • To emphasize the need for updated risk algorithms that incorporate new data and patient factors.
  • To highlight the importance of balancing statistical rigor with clinical and epidemiological judgment.

Main Methods:

  • Defining clear outcomes, follow-up periods, patient populations, and predictor variables for risk models.
  • Employing statistical models, such as stepwise regression, to identify optimal combinations of risk factors.
  • Considering non-linear effects and interactions of variables, alongside clinical and epidemiological expertise.

Main Results:

  • Risk model development necessitates precise definition of outcomes, populations, and predictors.
  • Statistical methods like stepwise regression aid in selecting relevant variables for predictive models.
  • The selection of variables requires a blend of statistical, clinical, and epidemiological insights.

Conclusions:

  • Cardiovascular risk models must be regularly updated to incorporate clinical advances and population changes.
  • Simple, generalizable models are preferred over complex ones that may overfit data.
  • Effective risk model development requires interdisciplinary expertise in statistics, clinical practice, and epidemiology.